Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: Denali org - You Need To See This

Andy Murray WITB: What Clubs Does The Tennis Legend Use?

Take a look at what's in the bag of former tennis star, turned golf addict, Andy Murray, who is already playing off a near scratch handicap

Golf Monthly

Denali Therapeutics Says AVLAYAH Launch Ahead of Expectations After Hunter Syndrome Approval

Denali Therapeutics (NASDAQ:DNLI) is seeing early commercial interest for its first approved drug, AVLAYAH, following its March 24 accelerated approval for Hunter syndrome, Chief Operating Officer and Chief Financial Officer Alexander Schuth said at a Bank of America Securities conference. Speaking

MarketBeat

'How Am I Supposed To Interpret This?': Man Stops Behind GMC Denali At Stoplight. Then He Realizes Something Odd About Its Design

Turn signals exist for one reason: to tell other drivers what you're about to do. They’re the only way you really have of communicating with other drivers, so when you send mixed signals, things can go bad quickly.

Motor1

From analysis to the latest developments in health,
read the most diverse news in one place.

The GMC Yukon Denali Needs An Identity: Review

The GMC Yukon occupies an odd space in GM's large SUV hierarchy. It’s essentially a higher-end version of the Chevrolet Tahoe, but it still slots well below the Cadillac Escalade. That’s a tough spot to be in when the Tahoe has a smaller price tag, and the Escalade sells on…

Motor1

Denali Flags Minimal Delay After FDA Halts Rare Disease Trial Start

The U.S. Food and Drug Administration (FDA) placed a clinical hold on Denali Therapeutics Inc.’s (NASDAQ:DNLI) investigational new drug (IND) application for the Phase 1 study of DNL952 under development for Pompe disease.

Benzinga

FDA Delays Decision Date For Denali Therapeutics' Lead Drug Candidate

The U.S. Food and Drug Administration extended on Monday Denali Therapeutics Inc.’s (NASDAQ:DNLI) review timeline of the Biologics License Application (BLA), seeking accelerated approval of tividenofusp alfa for the treatment of mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome.

Benzinga

The 2026 GMC Sierra EV Now Undercuts The Tesla Cybertruck By $15,000

General Motors’ EV assault is showing no signs of slowing down.

InsideEVs

Read news from The Economist, FT, and more,
with one subscription

Denali CEO Leads Fight Against Food Waste Epidemic

Denali addresses global food waste by recycling billions of pounds annually, promoting sustainability and circular economy practices.

Top News

Denali Launches New Lighting Accessories For The Ducati DesertX

Aftermarket adventure specialist Denali has launched a selection of lighting upgrades for the Ducati DesertX.

RideApart

Denali National Park worker dies after triggering avalanche

Officials in Alaska say a Denali National Park and Preserve employee died when he was caught in an avalanche while skiing in the backcountry, not far from the park’s entrance

The Independent UK

Auto review: Payne: Big ute in the big city, GMC Yukon Denali holidays in Chicago

CHICAGO — This is a big city. Big buildings. Big avenues. Big sports teams. Big shoulders. Big swagger.

Tribune News Service

Truck wars: GMC Sierra HD family gets beefier, techier, sexier

In the heavy duty pickup truck arms race, GMC has rolled out its latest weapon: the 2024 Sierra HD.

Tribune News Service

Tourists spot two of Denali National Park’s rarest critters

Denali National Park and Preserve on Saturday shared images of animals so elusive that even staff and frequent visitors rarely see them.

USA Today Sports Media Group

Get Adventure-Ready With Denali’s DialDim Lighting Controller

Denali introduces the DialDim lighting controller. Perfect for tourers and ADVs, it allows you to configure your lights in any way you please.

RideApart

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program

As previously announced, Denali Therapeutics Inc (NASDAQ: DNLI) was informed via e-mail communication from the FDA that DNL919 (ATV:TREM2) Investigational New Drug (IND) application was placed on clinical hold.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.